276 related articles for article (PubMed ID: 29787942)
1. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT).
Kaur D; Ashrani AA; Pruthi R; Khan SP; Bailey K; Rodriguez V
Thromb Res; 2018 Jul; 167():44-49. PubMed ID: 29787942
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.
Mitsuhashi K; Kako S; Shigematsu A; Atsuta Y; Doki N; Fukuda T; Kanamori H; Onizuka M; Takahashi S; Ozawa Y; Kurokawa M; Inoue Y; Nagamura-Inoue T; Morishima Y; Mizuta S; Tanaka J;
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2194-2200. PubMed ID: 27638362
[TBL] [Abstract][Full Text] [Related]
3. [Effect of BU and CY versus TBI and CY as conditioning regimens on the efficacy of haploidentical stem cell transplantation in patients with hematologic malignancy].
Shao Q; Han D; Liu D; Zheng X; Dong L; Wang Z; Ding L; Yan H; Wang H; Duan L
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):505-10. PubMed ID: 24985173
[TBL] [Abstract][Full Text] [Related]
4. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
[No Abstract] [Full Text] [Related]
5. Modified busulfan and cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of patients with hematologic malignancies.
Zhao XF; Mao XF; Wan DM; Liu W
Transplant Proc; 2014 Jun; 46(5):1531-5. PubMed ID: 24935325
[TBL] [Abstract][Full Text] [Related]
6. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
[TBL] [Abstract][Full Text] [Related]
7. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.
Pihusch R; Salat C; Schmidt E; Göhring P; Pihusch M; Hiller E; Holler E; Kolb HJ
Transplantation; 2002 Nov; 74(9):1303-9. PubMed ID: 12451270
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis in stem cell transplantation.
Kansu E
Hematology; 2012 Apr; 17 Suppl 1():S159-62. PubMed ID: 22507809
[TBL] [Abstract][Full Text] [Related]
10. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
11. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
[TBL] [Abstract][Full Text] [Related]
12. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
13. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.
Labrador J; López-Corral L; Vazquez L; Sánchez-Guijo F; Guerrero C; Sánchez-Barba M; Lozano FS; Alberca I; Del Cañizo MC; Caballero D; González-Porras JR
Br J Haematol; 2015 Jun; 169(5):719-25. PubMed ID: 25817436
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation].
Ma XJ; Ren HY; Qiu ZX; Cen XN; Ou JP; Wang WS; Xu WL; Wang LH; Dong YJ; Sun YH; Li Y; Yin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1007-12. PubMed ID: 20723318
[TBL] [Abstract][Full Text] [Related]
16. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Ishida S; Doki N; Shingai N; Yoshioka K; Kakihana K; Sakamaki H; Ohashi K
Ann Hematol; 2016 Jun; 95(7):1145-50. PubMed ID: 27079957
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
18. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
Ahmed I; Teruya J; Murray-Krezan C; Krance R
Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
[TBL] [Abstract][Full Text] [Related]
19. High incidence of BK virus-associated hemorrhagic cystitis in children after second or third allogeneic hematopoietic stem cell transplantation.
Umeda K; Kato I; Kawaguchi K; Tasaka K; Kamitori T; Ogata H; Mikami T; Hiramatsu H; Saito R; Ogawa O; Takahashi T; Adachi S
Pediatr Transplant; 2018 Jun; 22(4):e13183. PubMed ID: 29654658
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
